Article
Somatic Mutations and Mutation Burden Predict Treatment Response and Survival in Adult Acquired Pure Red Cell Aplasia.
American journal of hematology - 1 Jul 2026
Yang Liyan, Zhang Huiqin, Wei Yansong, Niu Haiyue, Liu Yumei, Zhang Tian, Xing Limin, Shao Zonghong, Fu Rong, Wang Huaquan
Abstract excerpt
Immunosuppressive therapy (IST) is the standard treatment for acquired pure red cell aplasia (aPRCA), but predictors of treatment response and long-term prognosis remain unclear. The clinical significance of somatic mutations in aPRCA is not fully understood. We retrospectively analyzed 69 adult aPRCA patients who underwent targeted next-generation sequencing of 69 genes associated with clonal hematopoiesis and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
